Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Breast Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 307 articles: HTML format

Single Articles

June 2008
1. KAKARALA M , Wicha MS
   Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
   J Clin Oncol. 2008;26:2813-20.
   PubMed     Related articles    Abstract available
   
   
   
2. JORDAN VC
   The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer--Survival or Death?
   J Clin Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. POLITE BN , Cirrincione C, Fleming GF, Berry DA, et al
   Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
   J Clin Oncol. 2008;26:2659-65.
   PubMed     Related articles    Abstract available
   
   
   
4. ANDRE F , Broglio K, Roche H, Martin M, et al
   Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
   J Clin Oncol. 2008;26:2636-43.
   PubMed     Related articles    Abstract available
   
   
   
5. AZIM AA , Costantini-Ferrando M, Oktay K
   Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
   J Clin Oncol. 2008;26:2630-5.
   PubMed     Related articles    Abstract available
   
   
   
6. CHEVILLE AL , Troxel AB, Basford JR, Kornblith AB, et al
   Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer.
   J Clin Oncol. 2008;26:2621-9.
   PubMed     Related articles    Abstract available
   
   
   
7. PARTRIDGE AH
   Fertility preservation: a vital survivorship issue for young women with breast cancer.
   J Clin Oncol. 2008;26:2612-3.
   PubMed     Related articles   
   
   
   May 2008
8. CODACCI-PISANELLI G , Spinelli GP, Tomao S
   Effect of epoetin on survival in patients with breast cancer.
   J Clin Oncol. 2008;26:2599.
   PubMed     Related articles   
   
   
   
9. RAKHA EA , Reis-Filho JS, Ellis IO
   Basal-like breast cancer: a critical review.
   J Clin Oncol. 2008;26:2568-81.
   PubMed     Related articles    Abstract available
   
   
   
10. ALLRED DC
    Problems and solutions in the evaluation of hormone receptors in breast cancer.
    J Clin Oncol. 2008;26:2433-5.
    PubMed     Related articles   
    
    
    
11. BADVE SS , Baehner FL, Gray RP, Childs BH, et al
    Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
    J Clin Oncol. 2008;26:2473-81.
    PubMed     Related articles    Abstract available
    
    
    
12. STORNIOLO AM , Pegram MD, Overmoyer B, Silverman P, et al
    Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. HOUSSAMI N , Ciatto S, Macaskill P, Lord SJ, et al
    Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. LEE AS , Ang P
    CHEK2*1100delC screening of Asian women with a family history of breast cancer is unwarranted.
    J Clin Oncol. 2008;26:2419.
    PubMed     Related articles   
    
    
    
15. GRAHAM PH
    Selection of a taxane as well as anthracycline for early breast cancer.
    J Clin Oncol. 2008;26:2416-7.
    PubMed     Related articles   
    
    
    
16. VAN DIJK S , van Roosmalen MS, Otten W, Stalmeier PF, et al
    Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
    J Clin Oncol. 2008;26:2358-63.
    PubMed     Related articles    Abstract available
    
    
    
17. PESTALOZZI BC , Zahrieh D, Mallon E, Gusterson BA, et al
    Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. GOMEZ HL , Doval DC, Chavez MA, Ang PC, et al
    Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. THOMAS ES
    Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
    J Clin Oncol. 2008;26:2223.
    PubMed     Related articles   
    
    
    
20. KATZ A , Smith BL, Golshan M, Niemierko A, et al
    Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    J Clin Oncol. 2008;26:2093-8.
    PubMed     Related articles    Abstract available
    
    
    
21. FISHER B , Redmond CK, Fisher ER
    Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.
    J Clin Oncol. 2008;26:2068-71.
    PubMed     Related articles   
    
    
    
22. RETTIG RA , Jacobson PD, Farquhar CM, Aubry WM, et al
    Randomized clinical trials, clinical use, and hope: what relationship?
    J Clin Oncol. 2008;26:2223-4.
    PubMed     Related articles   
    
    
    
23. SAMUEL TA , Subbannan K
    Horns of a dilemma.
    J Clin Oncol. 2008;26:2219-20.
    PubMed     Related articles   
    
    
    
24. BLANCHARD CM , Courneya KS, Stein K
    Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
    J Clin Oncol. 2008;26:2198-204.
    PubMed     Related articles    Abstract available
    
    
    
25. MARKS LB , Zeng J, Prosnitz LR
    One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate.
    J Clin Oncol. 2008;26:2075-7.
    PubMed     Related articles   
    
    
    
26. PIGNOL JP , Olivotto I, Rakovitch E, Gardner S, et al
    A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
    J Clin Oncol. 2008;26:2085-92.
    PubMed     Related articles    Abstract available
    
    
    April 2008
27. LIPTON A , Leitzel K, Chaudri-Ross HA, Evans DB, et al
    Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. BADGWELL BD , Giordano SH, Duan ZZ, Fang S, et al
    Mammography Before Diagnosis Among Women Age 80 Years and Older With Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. GREENSPAN SL , Brufsky A, Lembersky BC, Bhattacharya R, et al
    Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. CARDOSO F , Saghatchian M, Thompson A, Rutgers E, et al
    Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
    J Clin Oncol. 2008;26:2058-9.
    PubMed     Related articles   
    
    
    
31. BERNARDS R
    Reaction to American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
    J Clin Oncol. 2008;26:2057-8.
    PubMed     Related articles   
    
    
    
32. LIN NU , Carey LA, Liu MC, Younger J, et al
    Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
    J Clin Oncol. 2008;26:1993-9.
    PubMed     Related articles    Abstract available
    
    
    
33. BURZYKOWSKI T , Buyse M, Piccart-Gebhart MJ, Sledge G, et al
    Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.
    J Clin Oncol. 2008;26:1987-92.
    PubMed     Related articles    Abstract available
    
    
    
34. PICCART-GEBHART MJ , Burzykowski T, Buyse M, Sledge G, et al
    Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
    J Clin Oncol. 2008;26:1980-6.
    PubMed     Related articles    Abstract available
    
    
    
35. SARGENT DJ , Hayes DF
    Assessing the measure of a new drug: is survival the only thing that matters?
    J Clin Oncol. 2008;26:1922-3.
    PubMed     Related articles   
    
    
    
36. MAMOUNAS EP , Jeong JH, Wickerham DL, Smith RE, et al
    Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
    J Clin Oncol. 2008;26:1965-71.
    PubMed     Related articles    Abstract available
    
    
    
37. NGUYEN PL , Taghian AG, Katz MS, Niemierko A, et al
    Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. TRAINA TA , Theodoulou M, Feigin K, Patil S, et al
    Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    J Clin Oncol. 2008;26:1797-802.
    PubMed     Related articles    Abstract available
    
    
    
39. BRIASOULIS E , Roukos DH
    Contralateral prophylactic mastectomy: mind the genetics.
    J Clin Oncol. 2008;26:1909-10.
    PubMed     Related articles   
    
    
    
40. GIANNI L
    The "other" signaling of trastuzumab: antibodies are immunocompetent drugs.
    J Clin Oncol. 2008;26:1778-80.
    PubMed     Related articles   
    
    
    
41. DIGIOVANNA MP , Stern DF, Edgerton S, Broadwater G, et al
    Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer: Study 8541 From the Cancer and Leukemia Group B.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. MANDELBLATT JS , Cullen J, Lawrence WF, Stanton AL, et al
    Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer.
    J Clin Oncol. 2008;26:1684-90.
    PubMed     Related articles    Abstract available
    
    
    
43. DIXON JM , Renshaw L, Young O, Murray J, et al
    Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    J Clin Oncol. 2008;26:1671-6.
    PubMed     Related articles    Abstract available
    
    
    
44. GOODWIN JW , Green SJ, Moinpour CM, Bearden JD 3rd, et al
    Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
    J Clin Oncol. 2008;26:1650-6.
    PubMed     Related articles    Abstract available
    
    
    
45. SEIDMAN AD , Berry D, Cirrincione C, Harris L, et al
    Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Le
    J Clin Oncol. 2008;26:1642-9.
    PubMed     Related articles    Abstract available
    
    
    
46. LASH TL , Ahern TP, Cronin-Fenton D, Garne JP, et al
    Modification of tamoxifen response: what have we learned?
    J Clin Oncol. 2008;26:1764-5.
    PubMed     Related articles   
    
    
    
47. SPURDLE AB , Lakhani SR, Healey S, Parry S, et al
    Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
    J Clin Oncol. 2008;26:1657-63.
    PubMed     Related articles    Abstract available
    
    
    
48. NEVEN P , Brouckaert O, Van Belle V, Vanden Bempt I, et al
    In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
    J Clin Oncol. 2008;26:1768-9.
    PubMed     Related articles   
    
    
    March 2008
49. HAMEED O , Chhieng D, Adams AL
    Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.
    J Clin Oncol. 2008;26:1571.
    PubMed     Related articles   
    
    
    
50. PANT S , Landon MB, Blumenfeld M, Farrar W, et al
    Treatment of breast cancer with trastuzumab during pregnancy.
    J Clin Oncol. 2008;26:1567-9.
    PubMed     Related articles   
    
    
    
51. VIALE G , Regan MM, Maiorano E, Mastropasqua MG, et al
    Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    J Clin Oncol. 2008;26:1404-10.
    PubMed     Related articles    Abstract available
    
    
    
52. SCHNITT SJ , Harris JR
    Evolution of breast-conserving therapy for localized breast cancer.
    J Clin Oncol. 2008;26:1395-6.
    PubMed     Related articles   
    
    
    
53. RONDANINA G , Puntoni M, Severi G, Varricchio C, et al
    Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    J Clin Oncol. 2008;26:1537-43.
    PubMed     Related articles    Abstract available
    
    
    
54. ROYSTON P , Sauerbrei W
    Interactions between treatment and continuous covariates: a step toward individualizing therapy.
    J Clin Oncol. 2008;26:1397-9.
    PubMed     Related articles   
    
    
    
55. BURSTEIN HJ , Elias AD, Rugo HS, Cobleigh MA, et al
    Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. MUSOLINO A , Naldi N, Bortesi B, Pezzuolo D, et al
    Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
57. VERMA AK , Ramakant P
    Coronary artery disease after radiation therapy for early breast cancer.
    J Clin Oncol. 2008;26:1390.
    PubMed     Related articles   
    
    
    
58. LEWIS FM , Fletcher KA, Cochrane BB, Fann JR, et al
    Predictors of depressed mood in spouses of women with breast cancer.
    J Clin Oncol. 2008;26:1289-95.
    PubMed     Related articles    Abstract available
    
    
    
59. HORMES JM , Lytle LA, Gross CR, Ahmed RL, et al
    The body image and relationships scale: development and validation of a measure of body image in female breast cancer survivors.
    J Clin Oncol. 2008;26:1269-74.
    PubMed     Related articles    Abstract available
    
    
    
60. FOURNIER A , Fabre A, Mesrine S, Boutron-Ruault MC, et al
    Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
    J Clin Oncol. 2008;26:1260-8.
    PubMed     Related articles    Abstract available
    
    
    
61. DIRIX LY , Ignacio J, Nag S, Bapsy P, et al
    Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.
    J Clin Oncol. 2008;26:1253-9.
    PubMed     Related articles    Abstract available
    
    
    
62. SCHAAPVELD M , Visser O, Louwman MJ, de Vries EG, et al
    Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    J Clin Oncol. 2008;26:1239-46.
    PubMed     Related articles    Abstract available
    
    
    
63. DANG C , Fornier M, Sugarman S, Troso-Sandoval T, et al
    The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
    J Clin Oncol. 2008;26:1216-22.
    PubMed     Related articles    Abstract available
    
    
    
64. PACHMANN K , Camara O, Kavallaris A, Krauspe S, et al
    Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
    J Clin Oncol. 2008;26:1208-15.
    PubMed     Related articles    Abstract available
    
    
    
65. MAYER EL , Burstein HJ
    Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer.
    J Clin Oncol. 2008;26:1198-200.
    PubMed     Related articles   
    
    
    
66. BEAR HD
    Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
    J Clin Oncol. 2008;26:1195-7.
    PubMed     Related articles   
    
    
    
67. GOSS PE , Ingle JN, Pater JL, Martino S, et al
    Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. MUSS HB , Tu D, Ingle JN, Martino S, et al
    Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. TAN LK , Giri D, Hummer AJ, Panageas KS, et al
    Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. CRIVELLARI D , Sun Z, Coates AS, Price KN, et al
    Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. LIN NU , Winer EP
    Optimizing Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: Treating the Right Patients for the Right Length of Time.
    J Clin Oncol. 2008;.
    PubMed     Related articles   
    
    
    
72. KAUFF ND , Domchek SM, Friebel TM, Robson ME, et al
    Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
    J Clin Oncol. 2008;26:1331-7.
    PubMed     Related articles    Abstract available
    
    
    
73. HOLMBERG L , Garmo H, Granstrand B, Ringberg A, et al
    Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
    J Clin Oncol. 2008;26:1247-52.
    PubMed     Related articles    Abstract available
    
    
    
74. EWER MS , Lenihan DJ
    Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?
    J Clin Oncol. 2008;26:1201-3.
    PubMed     Related articles   
    
    
    
75. CHIA S , Gradishar W, Mauriac L, Bines J, et al
    Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor-Positive, Advanced Breast Cancer: Results From EFECT.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. IWASAKI M , Inoue M, Otani T, Sasazuki S, et al
    Plasma Isoflavone Level and Subsequent Risk of Breast Cancer Among Japanese Women: A Nested Case-Control Study From the Japan Public Health Center-Based Prospective Study Group.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. PUHALLA S , Mrozek E, Young D, Ottman S, et al
    Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. EASTELL R , Adams JE, Coleman RE, Howell A, et al
    Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
    J Clin Oncol. 2008;26:1051-7.
    PubMed     Related articles    Abstract available
    
    
    
79. DE PALMA R , Liberati A, Ciccone G, Bandieri E, et al
    Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
    J Clin Oncol. 2008;26:1033-9.
    PubMed     Related articles    Abstract available
    
    
    
80. BROUWERS MC , Somerfield MR, Browman GP
    A for effort: learning from the application of the GRADE approach to cancer guideline development.
    J Clin Oncol. 2008;26:1025-6.
    PubMed     Related articles   
    
    
    
81. DOWSETT M , Allred C, Knox J, Quinn E, et al
    Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
    J Clin Oncol. 2008;26:1059-65.
    PubMed     Related articles    Abstract available
    
    
    February 2008
82. PONZONE R , Sismondi P
    Patients with breast cancer are unlikely to benefit from prophylactic irradiation of the contralateral breast.
    J Clin Oncol. 2008;26:1014-5.
    PubMed     Related articles   
    
    
    
83. WOLOWACZ SE , Cameron DA, Tate HC, Bagust A, et al
    Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis.
    J Clin Oncol. 2008;26:925-33.
    PubMed     Related articles    Abstract available
    
    
    
84. LIGIBEL JA , Campbell N, Partridge A, Chen WY, et al
    Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.
    J Clin Oncol. 2008;26:907-12.
    PubMed     Related articles    Abstract available
    
    
    
85. GOODWIN PJ
    Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?
    J Clin Oncol. 2008;26:833-4.
    PubMed     Related articles   
    
    
    
86. MORGAN DA , Robertson JF
    Boost or not.
    J Clin Oncol. 2008;26:1013-4.
    PubMed     Related articles   
    
    
    
87. HADDAD TC , Yee D
    Of mice and (wo)men: is this any way to test a new drug?
    J Clin Oncol. 2008;26:830-2.
    PubMed     Related articles   
    
    
    
88. GUIX M , Granja Nde M, Meszoely I, Adkins TB, et al
    Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
    J Clin Oncol. 2008;26:897-906.
    PubMed     Related articles    Abstract available
    
    
    
89. KYNDI M , Sorensen FB, Knudsen H, Overgaard M, et al
    Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. HAFFTY BG , Buchholz TA, McCormick B
    Should IMRT Be the Standard of Care in the Conservatively Managed Breast Cancer Patient?
    J Clin Oncol. 2008;.
    PubMed     Related articles   
    
    
    
91. GRALOW JR , Burstein HJ, Wood W, Hortobagyi GN, et al
    Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    J Clin Oncol. 2008;26:814-9.
    PubMed     Related articles    Abstract available
    
    
    
92. WOLFF AC , Berry D, Carey LA, Colleoni M, et al
    Research issues affecting preoperative systemic therapy for operable breast cancer.
    J Clin Oncol. 2008;26:806-13.
    PubMed     Related articles    Abstract available
    
    
    
93. BUCHHOLZ TA , Lehman CD, Harris JR, Pockaj BA, et al
    Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
    J Clin Oncol. 2008;26:791-7.
    PubMed     Related articles    Abstract available
    
    
    
94. CHIA S , Swain SM, Byrd DR, Mankoff DA, et al
    Locally advanced and inflammatory breast cancer.
    J Clin Oncol. 2008;26:786-90.
    PubMed     Related articles   
    
    
    
95. BOWER JE
    Behavioral symptoms in patients with breast cancer and survivors.
    J Clin Oncol. 2008;26:768-77.
    PubMed     Related articles    Abstract available
    
    
    
96. GANZ PA , Hahn EE
    Implementing a survivorship care plan for patients with breast cancer.
    J Clin Oncol. 2008;26:759-67.
    PubMed     Related articles    Abstract available
    
    
    
97. PARTON M , Smith IE
    Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
    J Clin Oncol. 2008;26:745-52.
    PubMed     Related articles   
    
    
    
98. HODGSON NC , Gulenchyn KY
    Is there a role for positron emission tomography in breast cancer staging?
    J Clin Oncol. 2008;26:712-20.
    PubMed     Related articles    Abstract available
    
    
    
99. GRALOW JR , Zujewski JA, Winer E
    Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.
    J Clin Oncol. 2008;26:696-7.
    PubMed     Related articles   
    
    
    
100. LEVINE MN , Ganz PA, Mamounas EP
     Preface to Second Review Issue on Breast Cancer.
     J Clin Oncol. 2008;26:695.
     PubMed     Related articles   
     
     
     
101. LIN NU , Winer EP
     Advances in adjuvant endocrine therapy for postmenopausal women.
     J Clin Oncol. 2008;26:798-805.
     PubMed     Related articles    Abstract available
     
     
     
102. RASTOGI P , Anderson SJ, Bear HD, Geyer CE, et al
     Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
     J Clin Oncol. 2008;26:778-85.
     PubMed     Related articles    Abstract available
     
     
     
103. SCHOVER LR
     Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.
     J Clin Oncol. 2008;26:753-8.
     PubMed     Related articles    Abstract available
     
     
     
104. PRITCHARD KI , Messersmith H, Elavathil L, Trudeau M, et al
     HER-2 and topoisomerase II as predictors of response to chemotherapy.
     J Clin Oncol. 2008;26:736-44.
     PubMed     Related articles    Abstract available
     
     
     
105. CARDOSO F , Van't Veer L, Rutgers E, Loi S, et al
     Clinical application of the 70-gene profile: the MINDACT trial.
     J Clin Oncol. 2008;26:729-35.
     PubMed     Related articles    Abstract available
     
     
     
106. SPARANO JA , Paik S
     Development of the 21-gene assay and its application in clinical practice and clinical trials.
     J Clin Oncol. 2008;26:721-8.
     PubMed     Related articles    Abstract available
     
     
     
107. OREL S
     Who should have breast magnetic resonance imaging evaluation?
     J Clin Oncol. 2008;26:703-11.
     PubMed     Related articles    Abstract available
     
     
     
108. RUTGERS EJ
     Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
     J Clin Oncol. 2008;26:698-702.
     PubMed     Related articles    Abstract available
     
     
     
109. PEREZ EA , Suman VJ, Davidson NE, Sledge GW, et al
     Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
110. FIGUEIREDO JC , Bernstein L, Capanu M, Malone KE, et al
     Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. LIEDTKE C , Mazouni C, Hess KR, Andre F, et al
     Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. AAPRO M , Leonard RC, Barnadas A, Marangolo M, et al
     Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
     J Clin Oncol. 2008;26:592-8.
     PubMed     Related articles    Abstract available
     
     
     
113. EISINGER F
     CYP2D6 and Ockham's razor.
     J Clin Oncol. 2008;26:686-7.
     PubMed     Related articles   
     
     
     
114. WELLS RJ
     Secrecy and integrity in clinical trials.
     J Clin Oncol. 2008;26:680-2.
     PubMed     Related articles   
     
     
     
115. VELICER CM , Ulrich CM
     Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.
     J Clin Oncol. 2008;26:665-73.
     PubMed     Related articles    Abstract available
     
     
     
116. KAHN KL
     Moving research from bench to bedside to community: there is still more to do.
     J Clin Oncol. 2008;26:523-6.
     PubMed     Related articles   
     
     
     January 2008
117. GANZ PA , Hussey MA, Moinpour CM, Unger JM, et al
     Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
118. JOHNSTON S , Trudeau M, Kaufman B, Boussen H, et al
     Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
119. KAUFMAN EL , Jacobson JS, Hershman DL, Desai M, et al
     Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
     J Clin Oncol. 2008;26:392-8.
     PubMed     Related articles    Abstract available
     
     
     
120. MORROW M
     Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm.
     J Clin Oncol. 2008;26:352-3.
     PubMed     Related articles   
     
     
     
121. VERONESI U , Bonadonna G, Valagussa P
     Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
     J Clin Oncol. 2008;26:342-4.
     PubMed     Related articles   
     
     
     
122. SOLIN LJ , Orel SG, Hwang WT, Harris EE, et al
     Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
     J Clin Oncol. 2008;26:386-91.
     PubMed     Related articles    Abstract available
     
     
     
123. METCALFE KA , Lubinski J, Ghadirian P, Lynch H, et al
     Predictors of Contralateral Prophylactic Mastectomy in Women With a BRCA1 or BRCA2 Mutation: The Hereditary Breast Cancer Clinical Study Group.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
124. ANCHETA RG , Lewin H, Said J, Hurvitz SA, et al
     Primary dural marginal zone lymphoma in a woman with inflammatory breast cancer.
     J Clin Oncol. 2008;26:326-8.
     PubMed     Related articles   
     
     
     
125. DE MAEYER L , Van Limbergen E, De Nys K, Moerman P, et al
     Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
     J Clin Oncol. 2008;26:335-6.
     PubMed     Related articles   
     
     
     
126. TURNER RR , Weaver DL, Cserni G, Lester SC, et al
     Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training.
     J Clin Oncol. 2008;26:258-63.
     PubMed     Related articles    Abstract available
     
     
     
127. PARTRIDGE AH , Lafountain A, Mayer E, Taylor BS, et al
     Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
128. WEISCHER M , Bojesen SE, Ellervik C, Tybjaerg-Hansen A, et al
     CHEK*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls.
     J Clin Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
129. OFFIT K , Garber JE
     Time to Check CHEK2 in Families With Breast Cancer?
     J Clin Oncol. 2008;.
     PubMed     Related articles   
     
     
     
130. DE LAURENTIIS M , Cancello G, D'Agostino D, Giuliano M, et al
     Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.
     J Clin Oncol. 2008;26:44-53.
     PubMed     Related articles    Abstract available
     
     
     
131. SUSSWEIN LR , Skrzynia C, Lange LA, Booker JK, et al
     Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.
     J Clin Oncol. 2008;26:32-6.
     PubMed     Related articles    Abstract available
     
     
     
132. MALACRIDA S , Agata S, Callegaro M, Casella C, et al
     BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
     J Clin Oncol. 2008;26:26-31.
     PubMed     Related articles    Abstract available
     
     
     
133. DOMCHEK S , Weber BL
     Genetic variants of uncertain significance: flies in the ointment.
     J Clin Oncol. 2008;26:16-7.
     PubMed     Related articles   
     
     
     
134. STADTMAUER EA
     A dramatic story of hope and reality.
     J Clin Oncol. 2008;26:11-2.
     PubMed     Related articles   
     
     
     December 2007
135. BOURGIER C , Vozenin-Brotons MC, Arriagada R
     Enhanced local control by radiation boost in breast cancer: back side of the coin?
     J Clin Oncol. 2007;25:5841-3.
     PubMed     Related articles   
     
     
     
136. GULTEKIN M , Selek U, Ozyigit G, Cengiz M, et al
     Boost dose back again in elderly.
     J Clin Oncol. 2007;25:5843-4.
     PubMed     Related articles   
     
     
     
137. KOC M
     What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
     J Clin Oncol. 2007;25:5841.
     PubMed     Related articles   
     
     
     
138. LOVE RR , Van Dinh N, Quy TT, Linh ND, et al
     Survival After Adjuvant Oophorectomy and Tamoxifen in Operable Breast Cancer in Premenopausal Women.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. ROSSI E , Morabito A, De Maio E, Di Rella F, et al
     Endocrine Effects of Adjuvant Letrozole + Triptorelin Compared With Tamoxifen + Triptorelin in Premenopausal Patients With Early Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. OWUSU C , Buist DS, Field TS, Lash TL, et al
     Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor Positive Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. DEMICHELE A , Gimotty P, Botbyl J, Aplenc R, et al
     In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort".
     J Clin Oncol. 2007;25:5675-7.
     PubMed     Related articles   
     
     
     
142. CHEN JH , Mehta RS, Carpenter PM, Nalcioglu O, et al
     Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.
     J Clin Oncol. 2007;25:5667-9.
     PubMed     Related articles   
     
     
     
143. PEARSON SA , Ringland CL, Ward RL
     Use of Trastuzumab for Metastatic Breast Cancer in Australia: Interpreting Findings From a Cohort of 1,469 Women on a National Access Program Versus 41 Women Treated by Two Medical Oncologists.
     J Clin Oncol. 2007;25:5663-5664.
     PubMed     Related articles   
     
     
     
144. CHAN A , de Boer R
     Use of trastuzumab for metastatic breast cancer in Australia: inaccurate results and alternative interpretation of findings.
     J Clin Oncol. 2007;25:5662-3.
     PubMed     Related articles   
     
     
     
145. MILAM RA , Milam MR, Iyer RB
     Detection of early-stage ovarian cancer by FDG-PET-CT in a patient with BRCA2-positive breast cancer.
     J Clin Oncol. 2007;25:5657-8.
     PubMed     Related articles   
     
     
     
146. DENG G , Vickers A, Yeung S, Cassileth B, et al
     Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.
     J Clin Oncol. 2007;25:5584-90.
     PubMed     Related articles    Abstract available
     
     
     
147. CARPENTER JS , Flockhart D
     Flash points.
     J Clin Oncol. 2007;25:5546-7.
     PubMed     Related articles   
     
     
     
148. RAKOVITCH E , Pignol JP, Hanna W, Narod S, et al
     Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
     J Clin Oncol. 2007;25:5591-6.
     PubMed     Related articles    Abstract available
     
     
     
149. MEIJNEN P , Bartelink H
     Multifocal ductal carcinoma in situ of the breast: a contraindication for breast-conserving treatment?
     J Clin Oncol. 2007;25:5548-9.
     PubMed     Related articles   
     
     
     
150. JERUSS JS , Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, et al
     Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant Therapy.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. MOEDER CB , Giltnane JM, Harigopal M, Molinaro A, et al
     Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the american society of clinical oncology/college of american pathologists guidelines: tumor heterogeneity in breast cancer and its implicati
     J Clin Oncol. 2007;25:5418-25.
     PubMed     Related articles    Abstract available
     
     
     
152. MODI S , Stopeck AT, Gordon MS, Mendelson D, et al
     Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.
     J Clin Oncol. 2007;25:5410-7.
     PubMed     Related articles    Abstract available
     
     
     
153. EWER MS , Tan-Chiu E
     Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?
     J Clin Oncol. 2007;25:5532-3.
     PubMed     Related articles   
     
     
     
154. BUIJS C , Rodenhuis S, Seynaeve CM, van Hoesel QG, et al
     Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
     J Clin Oncol. 2007;25:5403-9.
     PubMed     Related articles    Abstract available
     
     
     November 2007
155. DAWSON SJ , Price MA, Jenkins MA, McKinley JM, et al
     Cancer Risk Management Practices of Noncarriers Within BRCA1/2 Mutation Positive Families in the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. ANSINK AC , Burger CW
     Oral contraceptives and breast cancer risk.
     J Clin Oncol. 2007;25:5327.
     PubMed     Related articles   
     
     
     
157. SCHROTH W , Antoniadou L, Fritz P, Schwab M, et al
     Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.
     J Clin Oncol. 2007;25:5187-93.
     PubMed     Related articles    Abstract available
     
     
     
158. DESTA Z , Flockhart DA
     Germline pharmacogenetics of tamoxifen response: have we learned enough?
     J Clin Oncol. 2007;25:5147-9.
     PubMed     Related articles   
     
     
     
159. CRUMP M , Gluck S, Tu D, Stewart D, et al
     Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
160. SCHEIER MF , Helgeson VS, Schulz R, Colvin S, et al
     Moderators of Interventions Designed to Enhance Physical and Psychological Functioning Among Younger Women With Early-Stage Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. MOURIDSEN H , Keshaviah A, Coates AS, Rabaglio M, et al
     Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
162. SOERJOMATARAM I , Coebergh JW, Louwman MW, Visser O, et al
     Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
     J Clin Oncol. 2007;25:5038-9.
     PubMed     Related articles   
     
     
     
163. DESHMANE V , Krishnamurthy S, Melemed AS, Peterson P, et al
     Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer.
     J Clin Oncol. 2007;25:4967-73.
     PubMed     Related articles    Abstract available
     
     
     
164. GOSS P , Bondarenko IN, Manikhas GN, Pendergrass KB, et al
     Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
     J Clin Oncol. 2007;25:4961-6.
     PubMed     Related articles    Abstract available
     
     
     
165. DIEZ O , Gutierrez-Enriquez S, Ramon y Cajal T, Alonso C, et al
     Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families.
     J Clin Oncol. 2007;25:5035-6.
     PubMed     Related articles   
     
     
     
166. HANRAHAN EO , Gonzalez-Angulo AM, Giordano SH, Rouzier R, et al
     Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
     J Clin Oncol. 2007;25:4952-60.
     PubMed     Related articles    Abstract available
     
     
     
167. BRENNER DJ , Shuryak I, Russo S, Sachs RK, et al
     Reducing second breast cancers: a potential role for prophylactic mammary irradiation.
     J Clin Oncol. 2007;25:4868-72.
     PubMed     Related articles   
     
     
     October 2007
168. THOMAS ES , Gomez HL, Li RK, Chung HC, et al
     Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. IGNATIADIS M , Xenidis N, Perraki M, Apostolaki S, et al
     Different Prognostic Value of Cytokeratin-19 mRNA-Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
170. TUTTLE TM , Habermann EB, Grund EH, Morris TJ, et al
     Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical Treatment.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
171. HARRIS L , Fritsche H, Mennel R, Norton L, et al
     American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
172. JONES SE , Cantrell J, Vukelja S, Pippen J, et al
     Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a tamoxifen exemestane adjuvant multicenter trial substudy.
     J Clin Oncol. 2007;25:4765-71.
     PubMed     Related articles    Abstract available
     
     
     
173. O'NEILL SC , Brewer NT, Lillie SE, Morrill EF, et al
     Women's interest in gene expression analysis for breast cancer recurrence risk.
     J Clin Oncol. 2007;25:4628-34.
     PubMed     Related articles    Abstract available
     
     
     
174. VOGEL KJ , Atchley DP, Erlichman J, Broglio KR, et al
     BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
     J Clin Oncol. 2007;25:4635-41.
     PubMed     Related articles    Abstract available
     
     
     
175. WOLF AM , Rumpold H, Wolf D, Gastl G, et al
     Role of forkhead box protein 3 expression in invasive breast cancer.
     J Clin Oncol. 2007;25:4499-500.
     PubMed     Related articles   
     
     
     
176. BARTLETT JM , Ellis IO, Dowsett M, Mallon EA, et al
     Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
     J Clin Oncol. 2007;25:4423-30.
     PubMed     Related articles    Abstract available
     
     
     
177. NIETO Y , Nawaz F, Jones RB, Shpall EJ, et al
     Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
     J Clin Oncol. 2007;25:4405-13.
     PubMed     Related articles    Abstract available
     
     
     
178. BONCZ I , Sebestyen A, Pinter I, Betlehem J, et al
     Age group specific gap between treatment cost of and mortality due to breast and colorectal cancer.
     J Clin Oncol. 2007;25:4501-2.
     PubMed     Related articles   
     
     
     September 2007
179. JORDAN VC , O'malley BW
     Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. FERRARIO C , Panasci LC
     Docetaxel plus cyclophosphamide in adjuvant breast cancer.
     J Clin Oncol. 2007;25:4327.
     PubMed     Related articles   
     
     
     
181. LIN WC , Chen JH
     Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors.
     J Clin Oncol. 2007;25:4308-10.
     PubMed     Related articles   
     
     
     
182. HARTMAN M , Czene K, Reilly M, Adolfsson J, et al
     Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
     J Clin Oncol. 2007;25:4210-6.
     PubMed     Related articles    Abstract available
     
     
     
183. DEBLED M , MacGrogan G, de Mascarel I, Brouste V, et al
     Expression profiling in breast carcinoma: new insights on old prognostic factors?
     J Clin Oncol. 2007;25:4316-7.
     PubMed     Related articles   
     
     
     
184. FABIAN CJ
     Low-dose tamoxifen for combination hormone replacement therapy users.
     J Clin Oncol. 2007;25:4162-4.
     PubMed     Related articles   
     
     
     
185. RAKHA EA , El-Sayed ME, Green AR, Paish EC, et al
     Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor Positive Phenotype.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
186. MOADEL AB , Shah C, Wylie-Rosett J, Harris MS, et al
     Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. COURNEYA KS , Segal RJ, Mackey JR, Gelmon K, et al
     Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. BREWSTER AM , Do KA, Thompson PA, Hahn KM, et al
     Relationship Between Epidemiologic Risk Factors and Breast Cancer Recurrence.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. SYMMANS WF , Peintingerw F, Hatzis C, Rajan R, et al
     Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
190. LIPTON A , Steger GG, Figueroa J, Alvarado C, et al
     Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. DEMARK-WAHNEFRIED W
     Move Onward, Press Forward, and Take a Deep Breath: Can Lifestyle Interventions Improve the Quality of Life of Women With Breast Cancer, and How Can We Be Sure?
     J Clin Oncol. 2007;.
     PubMed     Related articles   
     
     
     
192. VANG NIELSEN K , Jorgensen JT, Schonau A, Oster A, et al
     Human epidermal growth factor receptor 2 testing in breast cancer.
     J Clin Oncol. 2007;25:4020.
     PubMed     Related articles   
     
     
     
193. CREW KD , Greenlee H, Capodice J, Raptis G, et al
     Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
     J Clin Oncol. 2007;25:3877-83.
     PubMed     Related articles    Abstract available
     
     
     
194. FERGUSON RJ , McDonald BC, Saykin AJ, Ahles TA, et al
     Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
     J Clin Oncol. 2007;25:3866-70.
     PubMed     Related articles    Abstract available
     
     
     
195. LIM HS , Ju Lee H, Seok Lee K, Sook Lee E, et al
     Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.
     J Clin Oncol. 2007;25:3837-45.
     PubMed     Related articles    Abstract available
     
     
     
196. TYNDEL S , Austoker J, Henderson BJ, Brain K, et al
     What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group.
     J Clin Oncol. 2007;25:3823-30.
     PubMed     Related articles    Abstract available
     
     
     
197. BURSTEIN HJ , Winer EP
     Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
     J Clin Oncol. 2007;25:3797-9.
     PubMed     Related articles   
     
     
     
198. RAJI A
     Human epidermal growth factor receptor 2 testing recommendation.
     J Clin Oncol. 2007;25:4020-1.
     PubMed     Related articles   
     
     
     
199. PORTERA CC , Swain SM
     The heart of the matter.
     J Clin Oncol. 2007;25:3794-6.
     PubMed     Related articles   
     
     
     
200. SUTER TM , Procter M, van Veldhuisen DJ, Muscholl M, et al
     Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
     J Clin Oncol. 2007;25:3859-65.
     PubMed     Related articles    Abstract available
     
     
     August 2007
201. SOON WONG N , Seong Ooi W, Pritchard KI
     Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain.
     J Clin Oncol. 2007;25:3787.
     PubMed     Related articles   
     
     
     
202. MUSS HB , Berry DA, Cirrincione C, Budman DR, et al
     Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
     J Clin Oncol. 2007;25:3699-704.
     PubMed     Related articles    Abstract available
     
     
     
203. PEARSON SA , Ringland CL, Ward RL
     Trastuzumab and metastatic breast cancer: trastuzumab use in Australia--monitoring the effect of an expensive medicine access program.
     J Clin Oncol. 2007;25:3688-93.
     PubMed     Related articles    Abstract available
     
     
     
204. PARK JW , Melisko ME, Esserman LJ, Jones LA, et al
     Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer.
     J Clin Oncol. 2007;25:3680-7.
     PubMed     Related articles    Abstract available
     
     
     
205. MOURITS MJ , de Vries EG, ten Hoor KA, van der Zee AG, et al
     Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing.
     J Clin Oncol. 2007;25:3787-8.
     PubMed     Related articles   
     
     
     
206. BRADBURY AR , Dignam JJ, Ibe CN, Auh SL, et al
     How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
     J Clin Oncol. 2007;25:3705-11.
     PubMed     Related articles    Abstract available
     
     
     
207. BEVILACQUA JL , Kattan MW, Fey JV, Cody HS 3rd, et al
     Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
     J Clin Oncol. 2007;25:3670-9.
     PubMed     Related articles    Abstract available
     
     
     
208. LUCCI A , McCall LM, Beitsch PD, Whitworth PW, et al
     Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
     J Clin Oncol. 2007;25:3657-63.
     PubMed     Related articles    Abstract available
     
     
     
209. BUIST DS , Ichikawa L, Prout MN, Yood MU, et al
     Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care.
     J Clin Oncol. 2007;25:3428-36.
     PubMed     Related articles    Abstract available
     
     
     
210. FERRETTI G
     Forkhead box P3-positive regulatory T cells as therapeutic target for breast cancer.
     J Clin Oncol. 2007;25:e29.
     PubMed     Related articles   
     
     
     
211. TELLI ML , Hunt SA, Carlson RW, Guardino AE, et al
     Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.
     J Clin Oncol. 2007;25:3525-33.
     PubMed     Related articles    Abstract available
     
     
     
212. GIANNI L
     Ixabepilone and the narrow path to developing new cytotoxic drugs.
     J Clin Oncol. 2007;25:3389-91.
     PubMed     Related articles   
     
     
     
213. SMITH IE , Walsh G, Skene A, Llombart A, et al
     Neoadjuvant Anastrozole Alone or With Gefitinib in Early Breast Cancer: A Phase II Placebo-Controlled Trial (Study 223) With Biological and Clinical Outcomes.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
214. ANDERSON WF , Reiner AS, Matsuno RK, Pfeiffer RM, et al
     Shifting Breast Cancer Trends in the United States.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
215. VIALE G , Regan MM, Maiorano E, Mastropasqua MG, et al
     Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Women With Early Breast Cancer: Results From the BIG 1-98
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
216. BARTSCH R , Wenzel C, Altorjai G, Pluschnig U, et al
     Capecitabine and Trastuzumab in Heavily Pretreated Patients With Metastatic Breast Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
217. DE BOCK GH , Mourits MJ, Oosterwijk JC
     One risk fits all?
     J Clin Oncol. 2007;25:3383-4.
     PubMed     Related articles   
     
     
     
218. DE LIMA LOPES G JR , Gluck S
     Health economics in the Journal of Clinical